Lisinopril and Exalgo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Exalgo (hydromorphone hydrochloride). Common drug interactions include eye movement disorder among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Exalgo. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Exalgo?

Exalgo has active ingredients of hydromorphone hydrochloride. It is often used in chronic pain. eHealthMe is studying from 9,847 Exalgo users. Check the latest studies of Exalgo.



On Jul, 16, 2026

44 people who take Lisinopril and Exalgo together, and have interactions are studied.

Lisinopril and Exalgo drug interactions.

What are the common drug interactions of Lisinopril and Exalgo, by gender? *:

female:

  1. Eye movement disorder
  2. Fall
  3. Feeding disorder (when children refuse to eat certain food groups)
  4. Feeling jittery
  5. Fluid imbalance (imbalance of fluid in body in intake and fluid lost)
  6. Gastric disorder (disease of stomach)
  7. Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
  8. Gastroenteritis (inflammation of stomach and intestine)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Gastrointestinal injury (injury to gastrointestinal tract)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Oedema (fluid collection in tissue)
  4. Pulmonary infarction (death of a small area of lung)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Diarrhoea
  7. Nausea (feeling of having an urge to vomit)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Nephrolithiasis (calculi in the kidneys)
  10. Vomiting

What are the common drug interactions of Lisinopril and Exalgo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cellulitis (infection under the skin)

40-49:

  1. Drug ineffective
  2. Back pain
  3. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  4. Cough
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Dyspnoea (difficult or laboured respiration)
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Oxygen saturation decreased
  9. Speech disorder
  10. Urinary incontinence (inability to control the flow of urine and involuntary urination)

50-59:

  1. Diarrhoea
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Fatigue (feeling of tiredness)
  4. Feeling jittery
  5. Hot flush (sudden feelings of heat)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site reaction
  9. Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
  10. Insomnia (sleeplessness)

60+:

  1. Drug ineffective
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  5. Asthenia (weakness)
  6. Asthma
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Atrioventricular block (heart block)
  9. Back pain
  10. Blood creatinine increased

What are the existing conditions these people have? *

  1. Depression: 18 people, 40.91%
  2. Stress And Anxiety: 16 people, 36.36%
  3. High Blood Cholesterol: 15 people, 34.09%
  4. Diabetes: 13 people, 29.55%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 29.55%
  6. Muscle Spasms (muscle contraction): 11 people, 25.00%
  7. Restless Leg Syndrome (a powerful urge to move your legs): 11 people, 25.00%
  8. Nausea (feeling of having an urge to vomit): 11 people, 25.00%
  9. Insomnia (sleeplessness): 10 people, 22.73%
  10. Cough: 10 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Exalgo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Exalgo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exalgo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exalgo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and hydromorphone hydrochloride (the active ingredients of Lisinopril and Exalgo, respectively), and Lisinopril and Exalgo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: